The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene

F A Spring, R Dalchau, G L Daniels, G Mallinson, P A Judson, S F Parsons, J W Fabre, D J Anstee, F A Spring, R Dalchau, G L Daniels, G Mallinson, P A Judson, S F Parsons, J W Fabre, D J Anstee

Abstract

The Ina and Inb blood group antigens were found to be located on an erythrocyte membrane glycoprotein of 80,000 MW by immunoblotting with human anti-Ina and anti-Inb antibodies under non-reducing conditions. This glycoprotein is shown here to be identical to that defined by monoclonal antibodies to CDw44, and a new murine monoclonal antibody (BRIC 35) is added to this cluster. Experiments with endo-beta-galactosidase and Endo F preparations suggest that the glycoprotein contains one or more N-glycans but that these oligosaccharides do not contain extensive poly-N-acetyllactosaminyl sequences. Experiments using membranes prepared from sialidase-treated normal erythrocytes, from Tn erythrocytes and from Cad erythrocytes suggest that the glycoprotein does not contain a substantial content of O-glycans. The Inb antigen and the epitope defined by a murine monoclonal antibody (BRIC 35) show reduced expression on Lu(a-b-) erythrocytes which result from the effect of the dominant inhibitor gene In(Lu). Evidence is presented here that the Inb antigen is expressed on normal granulocytes and lymphocytes and on the haemopoietic cell lines HEL, K562 and HL-60, a lymphoblastoid cell line and lymphocytes from two patients with B-CLL.

References

    1. Rev Fr Transfus. 1968 Oct 3;11(3):209-21
    1. Arch Biochem Biophys. 1963 Jan;100:119-30
    1. Vox Sang. 1974;26(4):400-1
    1. Vox Sang. 1975;29(1):73-6
    1. Med Lab Sci. 1977 Jan;34(1):1-6
    1. Eur J Immunol. 1980 Oct;10(10):745-9
    1. Biochemistry. 1980 Dec 9;19(25):5734-41
    1. Semin Hematol. 1981 Jan;18(1):63-71
    1. Lancet. 1981 Aug 29;2(8244):434-8
    1. Br J Haematol. 1982 May;51(1):107-15
    1. J Neurochem. 1982 Nov;39(5):1461-6
    1. Eur J Cancer Clin Oncol. 1983 Feb;19(2):209-20
    1. J Clin Invest. 1983 Jun;71(6):1878-86
    1. Br J Haematol. 1983 Aug;54(4):573-8
    1. J Immunol. 1983 Sep;131(3):1195-200
    1. Immunology. 1983 Nov;50(3):415-22
    1. Blood. 1984 Sep;64(3):599-606
    1. J Immunol. 1985 Feb;134(2):1276-85
    1. Mol Immunol. 1985 Feb;22(2):113-24
    1. Biochem J. 1985 Jan 15;225(2):291-9
    1. Hum Immunol. 1985 Jul;13(3):199-209
    1. Neurosci Lett. 1985 Sep 6;59(3):253-7
    1. J Immunol. 1986 Jan;136(1):118-24
    1. Transfusion. 1986 Mar-Apr;26(2):171-2
    1. Biochem J. 1986 Jan 1;233(1):93-8
    1. Biochem J. 1986 Mar 15;234(3):649-52
    1. Neurochem Res. 1986 Jun;11(6):877-89
    1. Vox Sang. 1986;51(1):49-52
    1. Eur J Immunol. 1986 Oct;16(10):1195-202
    1. Hum Immunol. 1986 Nov;17(3):311-24
    1. Immunology. 1987 Oct;62(2):307-13
    1. Nature. 1963 May 25;198:796
    1. Nature. 1970 Aug 15;227(5259):680-5

Source: PubMed

3
Abonner